Holdings
Perceptive Advisors LLC
As of Sep 30, 2026, Perceptive Advisors LLC reported 90 positions worth US$4.95B. Largest: Praxis Precision Medicines, Inc., Amylyx Pharmaceuticals, Inc. and Spyre Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 2.02M | US$590M | −11,205 | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 10.6M | US$308M | +2.24M | Sep 30, 2026 |
| Spyre Therapeutics, Inc. | 3.28M | US$292M | −1.04M | Sep 30, 2026 |
| Celcuity Inc. | 3.18M | US$253M | −17,406 | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 2.53M | US$241M | −53,739 | Sep 30, 2026 |
| Roivant Sciences Ltd. | 6.51M | US$238M | −1.57M | Sep 30, 2026 |
| Relay Therapeutics, Inc. | 12.7M | US$230M | −1.38M | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 3.54M | US$209M | −210K | Sep 30, 2026 |
| Freenome, Inc. | 12.6M | US$199M | new | Sep 30, 2026 |
| Edgewise Therapeutics, Inc. | 4.14M | US$168M | −236K | Sep 30, 2026 |